Surgery Partners (NASDAQ:SGRY) Reaches New 1-Year Low – Time to Sell?

Surgery Partners, Inc. (NASDAQ:SGRY)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as $21.02 and last traded at $21.03, with a volume of 456980 shares trading hands. The stock had previously closed at $21.55.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on SGRY. KeyCorp started coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Macquarie reissued an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research note on Tuesday, November 19th. Benchmark restated a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a report on Monday, August 26th. JPMorgan Chase & Co. cut their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a report on Tuesday, December 3rd. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a report on Friday, October 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $37.38.

Surgery Partners Trading Up 0.5 %

The stock’s fifty day moving average price is $26.93 and its 200 day moving average price is $27.95. The stock has a market cap of $2.59 billion, a P/E ratio of -42.42, a PEG ratio of 17.95 and a beta of 2.58. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. During the same period in the previous year, the firm earned $0.15 EPS. The company’s revenue was up 14.3% on a year-over-year basis. Equities research analysts expect that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Institutional Trading of Surgery Partners

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Quarry LP raised its stake in shares of Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares during the last quarter. KBC Group NV raised its position in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after buying an additional 576 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its stake in Surgery Partners by 747.6% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after acquiring an additional 3,379 shares during the period. Creative Planning purchased a new stake in shares of Surgery Partners during the 3rd quarter valued at about $258,000. Finally, Versor Investments LP purchased a new stake in shares of Surgery Partners during the 3rd quarter valued at about $271,000.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.